Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
I’m not defending what Novartis did or trying to find an excuse for the company. It violated the FCPA, and (along with a former subsidiary) paid nearly $347 million in penalties and disgorgement to resolve the offenses.… Continue Reading
During the second calendar quarter — amid the Covid-19 lockdown — there were two corporate FCPA enforcement actions. For comparison, during the second calendar quarter last year, there were three corporate FCPA enforcement actions, and during Q2 2018, there were five corporate FCPA enforcement actions.… Continue Reading
Pharmaceutical giant Novartis AG and two subsidiaries (one current and one former) agreed Thursday to pay the DOJ and SEC $346.7 million in penalties and disgorgement to resolve FCPA offenses in Greece, Vietnam, and South Korea.… Continue Reading
Job Title: Executive Director, E&C Head of Policy & Strategic Excellence
Employer: Novartis
Location: East Hanover, New Jersey USA
Description: The position is responsible for leading the Ethics & Compliance (E&C) Policy & Strategic Excellence group.… Continue Reading
Job Title: Executive Director, E&C Head of Policy & Strategic Excellence
Employer: Novartis
Location: East Hanover, New Jersey USA
Description: The position is responsible for leading the Ethics & Compliance (E&C) Policy & Strategic Excellence group.… Continue Reading
Dr. Klaus MoosmayerBig pharma Novartis said Tuesday that it named Dr. Klaus Moosmayer as its new Chief Ethics, Risk and Compliance Officer.
He’ll report to the CEO, Vas Narasimhan, and become a member of Novartis’ Executive Committee.… Continue Reading
Job Title: Director, Ethics & Compliance Franchise Advisor: Ophtha/Respiratory
Employer: Novartis
Location: East Hanover, New Jersey USA
Description: To provide independent, strategic business partnership with Franchise Leadership of two Franchises (Ophthalmics/Respiratory) to anticipate and identify proactive strategies/solutions to address business needs and potential risks, and help ensure that activities and processes comply with all applicable NPC policies, laws, regulations and professional codes of conduct.… Continue Reading
Job Title: Director, Ethics & Compliance Functional Advisor, Patient Access/Health Policy
Employer: Novartis
Location: East Hanover, New Jersey USA
Description: To provide independent, strategic business partnership with the Patient Access/Health Policy (PA/HP) Function to anticipate and identify proactive strategies/solutions to address business needs and potential risks, and help ensure that activities and processes comply with all applicable NPC policies, laws, regulations and professional codes of conduct.… Continue Reading
South Korea Thursday fined Swiss pharma Novartis $48.3 million for paying doctors kickbacks to prescribe the company’s drugs.
The Ministry of Health and Welfare also made a preliminary decision to suspend insurance coverage for six month on some Novartis drugs.… Continue Reading
Pharmaceuticals companies continue to fall foul of the FCPA and other anti-bribery laws, with a number of 2016 cases suggesting a vulnerability around marketing practices especially in the Asia-Pacific region. Why does a sector that is way ahead of the compliance game in so many ways keep getting caught out by anti-bribery laws?… Continue Reading
Last month Forest Labs paid $38 million to settle allegations it paid doctors speaker fees for sometimes phony events so they would prescribe its drugs. It was the latest in a string of “speaker fee” cases.… Continue Reading
It is customary to send gifts and make cash donations in the regular course of business in South Korea. Exchanging gifts is a deeply rooted custom in Korean society, and this practice has historically been the source of various compliance issues for multinational companies operating in South Korea.… Continue Reading
